News
America Wants to Make More Generic Drugs. India Shows Why That’s Hard.
Cheap labor and global supply chains are among the obstacles to President Trump’s plan to bring generic drug manufacturing back home.
More in Business
- G7 nations to release diesel stocks as wars in Europe and Middle East constrain fuel supplies CNBC — World News
- U.S. and Allies Agree to Release Diesel Reserves as Prices Soar The New York Times — Business
- ‘Complete disruption of the economy is all but certain’: Top jobs and home prices are at risk, a new report on AI says MarketWatch
- She gave up her US Green Card to return to India and build her startup from scratch: Meet Bharathi Ramesh Mint
- Nasdaq hits record high after weaker-than-expected US jobs report – business live The Guardian — Business